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METHODS
The experimental animals consisted of 40 pig-
mented and 40 albino 2½ month old, random-
bred, female hairless mice. They were housed in
metal cages and fed on unrestricted quantities of
Wayne Laboratory Blox and water. The ultra-
violet source was an Hanovia air-cooled, high-
pressure mercury contact lamp. This lamp emits
2.12 X 10 ergs/cm2/sec. of mid-ultraviolet energy
(2800—3200 A) at a distance of 3.4 cm. Measure-
ments of the energy output were made with an
Hanovia ultraviolet meter (Model ZV-971).
Each mouse received a 5 second exposure of
ultraviolet to the posterior third of the back three
times a week. By 10 weeks the pigmented mice
had developed deeply melanotic plaques, and the
albino animals developed erythematous non-
melanotic plaques at the irradiated sites (Fig. 1).
The ultraviolet radiation was discontinued at this
time, and each of the animals was given a single
intraperitoneal injection of 0.5 mg chloroquine
diphosphate (equal to 0.4 mg chioroquine base).
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Equal numbers of the albino and pigmented ani-
mals were sacrificed at 24, 48, and 72 hours, and
then weekly for three weeks. Specimens of skin
for histologic studies were obtained and the ir-
radiated areas were excised from the remainder of
the skin. An additional albino and pigmented
animal was sacrificed at each time period for
determination of the dry weight of the tissue, since
most of the specimens were too small to afford an
aliquot for dry weight calculations. Dry weighing
was performed by drying the skin in a vacuum
oven at 900 C for 24 hours. The assay procedure
followed was modified from that described by
Brodie et al. (4).
Each skin specimen was weighed, cut into fine
pieces with scissors, and ground at 10° C with 12
ml 0.1 N HC1 for 2 minutes in a Servall Omni-
Mixer. The material was then transferred to a 50
ml glass-stoppered centrifuge tube containing 9
ml 02 N NaOH and 10 ml heptane. The tubes
were shaken vigorously for 30 minutes, centrifuged
at 5,000 X g for 15 minutes, and the heptane phase
containing the chioroquine removed. The heptane
was washed X 2 with 0.1 N NaOH and finally
extracted into 2 ml 0.1 N Rd. Three drops of
ethanol were added at each step to decrease ad-
sorption of chloroquine to the glass of the tubes.
For fluorometry, 1.6 ml of the 0.1 N HCl contain-
ing the chioroquine was transferred to a fluorom-
eter tube containing 0.33 ml 0.5 N NaOH and 0.5
ml boric acid buffer, (5 vols 0.6 M boric acid in
0.6 M KCI added to 3.2 vols 0.6 N NaOH). To
each tube was added 0.16 ml of neutral 1.0 M 1-
cysteine HC1 to prevent oxidation of the chloro-
quine during irradiation. After 30 minutes, to allow
for reaction between cysteine and oxygen, the
tubes were irradiated for 1 hour with ultraviolet
light from a Burdick high pressure mercury lamp
type QA-450-N at a distance of 18 inches. The
amount of fluorescence which developed was read
in a Turner Fluorometer (Model 111), using a
Corning 7-60 as the primary filter (passes light
below 365 m) and a 110-816 (2A) as the second-
ary filter (passes light above 415 me). The instru-
ment was zeroed with a blank and readings were
compared with standard solutions of chioroquine
handled in exactly the same manner as the un-
knowns. In addition, the skin of animals which
had not been injected with chioroquine was as-
sayed to determine the amount of interfering
fluorescence in skin itself. This value was found
to be consistently very low but constantly present
and was subtracted from the actual determinations
of chioroquine levels.
RE SUITS
Histologic examination revealed hyperkera-
tosis, hypergranulosis, acanthosis, and a thick-
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The localization of chioroquine in areas of
melanin pigmentation has recently been estab-
lished. Zvaifier and his co-workers (1) found
that the concentration of this drug in the eyes
of pigmented rats paralleled the degree of mela-
nin pigmentation. In addition, they noted that
chloroquine persists at high levels in the iris
and choroid for at least 28 days whereas the
concentration decreases rapidly in the other tis-
sues examined (2). However, in the studies of
Zvaifler et al., no information was obtained for
skin pigment. A study of the possible affinity
of chioroquine for skin melanin became feasible
with the acquisition of a strain of pigmented
hairless mice which develop melanotie plaques
at sites of repeated ultraviolet irradiation (3).
ened dermis, with an increased number of mast
cells, flbrocytcs, and inflammatory cells in both
the amelanotic and melanotic plaques (Figs.
2 and 3). The tissues of the pigmented mice dif-
fered from that of the albino mice only in the
dense accumulation of dermal melanocytes and
melanin in the pigmented areas. (The pigment
stained positively for melanin with the Fontana
stain). The non-irradiated skin of these animals
showed an epidermis of 2—3 cell layers and a
thin dermis with degenerating hair follicles,
epithelial cysts, and some mast cells, (Figs. 4
and 5). In contrast to the normal skin of the
albino, the normal skin of the pigmented mice
contained a few scattered dermal melanocytes.
The results of the chioroquine assays are pre-
sented in Table I. In addition, the differences
between the chloroquine concentrations in the
irradiated and non-irradiated skin are presented
graphically in Figure 6.
Twenty-four hours after the single injection,
similar amounts of chloroquine were found in
the skin of the albino and pigmented mice
though the irradiated areas showed much higher
values in both types of animals. By 48 hours
the concentration in the non-irradiated skin of
both the albino and pigmented mice had fallen
to undetectable levels. The amount of chioro-
quine present in the irradiated albino tissue was
also reduced, but significant levels were still
present at 72 hours. By 7 days no chloroquine
was detectable in any part of the albino skin.
In contrast, the concentration of the drug in
the irradiated plaques of the pigmented mice
increased over the first 2 days, reaching its
peak at 48 hours. Though some reduction of the
chioroquine concentration in these pigmented
tissues occurred thereafter, significant levels per-
sisted for at least three weeks. Pigmented skin
has not yet been examined for its chioroquine
content after more than three weeks subsequent
to administration of the drug.
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Fm. 1. An albino hairless mouse on the right and a pigmented mouse on the left. Both
animals have received 10 weeks of ultraviolet light to the posterior third of the back. The
melanotic plaque is evident in the pigmented mouse.
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FIG. 2. Albino plaque showing hyperkeratosis, hypergranulosis, acanthosis and thickening
of the dermis with accumulation of fibrocytes and mast cells.
FIG. 3. Pigmented plaque showing hyperkeratosis, hypergranulosis, acanthosis and thicken-
ing of the dermis with accumulation of fibrocytes and mast cells. A dense accumulation of
melanin and melanocytes is present in the mid dermis (p). The acanthosis present in the
amelanotic plaque, (Fig. 2), is more striking than that seen in the melanotic plaque, (Fig.
3). This difference was neither a consistent nor a significant variation in the response of these
two skin types to radiation.
DISCUSSION
Clinical observations have established that
pigmentary abnormalities occur in a significant
number of patients receiving chloroquine ther-
apy (5—7). These changes consist primarily of
loss of hair color and formation of blue-black
pigmented patches involving pretibial, facial,
and palatal areas. Histologically, this skin and
mucosal discoloration apparently is due to the
deposition of clumped yellow to dark brown
pigment in the dermis. Recent studies suggest
that similar alterations in the ocular pigment
system may be related to the irreversible retinal
damage that has been reported following long
term chioroquine administration (8—10).
The mechanism or mechanisms responsible
for the pigmentary aberrations are not clear.
The results of our study as well as those re-
ported by Zvaifier et al. (1, 2) indicate that
chloroquine not only has a remarkable affinity
for cutaneous and ocular melanin, but that it
is not readily released from the pigmented I s-
sues. Thus, this drug most likely has a dir ct
effect on the pigment systems. The in rn€ro
studies of Perez et al. (11) suggest that chloro-
quine binding to melanin may be mediated
through a charge transfer process. In vivo data,
however, have been difficult to obtain, partly
because of the limited amount of tissue available
for study when the eye is used for study. The
cutaneous pigmented plaque described in the
present paper affords a larger pigmented model
for more thorough in vivo evaluation of the pig-
mentary alterations.
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Fie. 4. Normal skin of the albino showing a 2 to 3 layer epidermis, and a thin dermis with
sebaceous glands, epithelial cysts and degenerated hair follicles.
FIG. 5. Normal skin of the pigmented mouse.
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TABLE I
Comparison of the chloroquine concentration of the irradiated and non-irradiated skin of
pigmented and albino mice following intra-peritoneal injection
of chioroquine diphosphate
PIGMENTED ALBINO
Time after Injectior,
Irradiated Non-irradiated Difference
Number of
Animals Irradiated
Non-
irradiated Difference
Number of
Animals
24 hours
48 hours
72 hours
2.80
3.07
1.94
0.67
0
0
2.18
3.07
1.94
6
4
2
3.90
1.16
1.09
0.92
0
0
2.98
1.16
1.09
4
3
2
lweek
2 weeks
3 weeks
1.54
2.63
1.07
0
0
0
1.54
2.63
1.07
2
2
6
0
0
0
0
0
0
0
0
0
4
4
6
The values given are averages of the total number of animals in each group, expressed as micrograms
of chloroquine per gram dry weight of skin.
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FIG. 6. Graphic representation of the difference in the chioroquine levels in the irradiated
and non-irradiated skin of albino and pigmented mice.
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SUMMARY
By the use of pigmented hairless mice which
developed a darkly melanotie plaque at the site
of ultraviolet irradiation, it has been possible
to demonstrate the affinity of dermal melanin
for chioroquine. The ehloroquine levels in the
albino control mice, which developed non-mela-
notie plaques at the irradiated sites, fell rapidly
to zero within one week after a single intra-
peritoneal injection of the drug. The melanotic
plaques of the pigmented mice, on the other
hand, contained high levels of chloroquine for
at least three weeks. Thus, the hairless mouse
provides a model for studying the binding of
drugs to melanin.
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DISCUSSION
Da. THOMAS B. FITZPATRICK, Boston, Mass.:
These two papers illustrate what we have known
for a long time from enzymic and electronmicro-
scopic studies of the melanin in the retinal pig-
ment epithelium. Melanin formation begins in
the retinal pigment epithelium before it occurs
in the melanin-forming cells of any other part
of the melanocyte system. This is beautifully
illustrated in the chick embryo which has very
large eyes that darken early in the course of
development, i.e., within the first few days.
In the chick, melanin is formed in the retinal
pigment epithelium before it is formed in other
parts of the melanocyte system; melanin forma-
tion also ceases in this tissue earlier than in
other parts of the system. Enzymic studies pro-
vide no evidence that melanin formation con-
tinues in the retinal pigment epitheliuin of the
chick after the 18th day of development. In
man, events follow a similar course. This would
explain the relatively slow turnover of chioro-
quine since the melanosomes and melanin gran-
ules of the retinal pigment epithelium are not
ejected from melanocytes into Malpighian cells
as they are in the epidermis and the hair bulb.
DR. lvi. A. PATHAK, Boston, Mass.: I would
like to know why the authors did not inject
chloroquine in the first ten-week period when
the mice were being irradiated. I feel that the
binding or incorporation of chloroquine in to
melanin would be more during the first ten-week
period. At this time the process of melanogenesis
(new melanin formation) would be progressing
much more rapidly. During this interval the
synthesis of premelanosomes, melanosomes and
melanin granules would be greatly augmented
and hence the incorporation or binding of chloro-
quine during melanogenesis would be more likely
to be augmented.
Da. W. MITCHELL SAMS, Ja. (in closing): I
would like to thank the discussors for their
comments. In answer to Dr. Fitzpatrick's ques-
tion about rates of turnover, the turnover rate
of chloroquine is not necessarily related to the
turnover rate of melanin. This is because the
binding of chloroquine to melanin is most likely
by a charge transfer process since eliloroquine
is a fair electron donor and melanin is a rather
good acceptor (Szent-Gyorgyi, A., An Introduc-
tion to Submolecular Biology and Perez et al,
Arthr. and Rheu. 7: 337, 1964). This bond is
probably not very strong, not nearly as strong
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as with chlorpromazine (which is a superb elec-
tron donor), and thus the chioroquine might
be "washed off" the melanin molecule long
before the latter turned over. In reply to Dr.
Pathak, ultraviolet irradiation of the animals
was stopped prior to injection of chloroquine.
Dr. Stoughton asked if this binding phenomenon
could be related to the amount of melanin in
the retina and macular degeneration of the
latter. The answer, at this point, is that this
seems likely but is not proven. It is well known,
however, that chloroquine can be found in much
higher concentration in the pigmented iris and
choroid than in the non-pigmented cornea,
retina, and sclera. (Zvaifler et at, Arth. and
Rheu. 5: 667, 1962.) Some of the known indi-
viduals who have developed macular degenera-
tion have been Negroes, who would be expected
to have large amounts of ocular melanin, while
others have been Caucasians. The total number,
however, is not sufficient at present to make any
statistical evaluation.
